![Anita Cooper](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anita Cooper
Direttore/Membro del Consiglio presso Rarecan Ltd.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Fabrice Chartier | M | 59 |
Simbec-Orion Group Ltd.
![]() Simbec-Orion Group Ltd. Pharmaceuticals: MajorHealth Technology Simbec-Orion Group Ltd. provides contract research services for rare and orphan conditions. The firm offers services for oncology, orphan diseases, respiratory, dermatology, infectious vaccines and diseases. The company was founded in 2014 and is headquartered in Pentrebach, the United Kingdom. | 27 anni |
Aize Smink | M | - |
Simbec-Orion Group Ltd.
![]() Simbec-Orion Group Ltd. Pharmaceuticals: MajorHealth Technology Simbec-Orion Group Ltd. provides contract research services for rare and orphan conditions. The firm offers services for oncology, orphan diseases, respiratory, dermatology, infectious vaccines and diseases. The company was founded in 2014 and is headquartered in Pentrebach, the United Kingdom. | 3 anni |
John Gahan | M | 54 |
Simbec-Orion Group Ltd.
![]() Simbec-Orion Group Ltd. Pharmaceuticals: MajorHealth Technology Simbec-Orion Group Ltd. provides contract research services for rare and orphan conditions. The firm offers services for oncology, orphan diseases, respiratory, dermatology, infectious vaccines and diseases. The company was founded in 2014 and is headquartered in Pentrebach, the United Kingdom. | 5 anni |
Ceri Edwards | F | - |
Simbec-Orion Group Ltd.
![]() Simbec-Orion Group Ltd. Pharmaceuticals: MajorHealth Technology Simbec-Orion Group Ltd. provides contract research services for rare and orphan conditions. The firm offers services for oncology, orphan diseases, respiratory, dermatology, infectious vaccines and diseases. The company was founded in 2014 and is headquartered in Pentrebach, the United Kingdom. | - |
Chris Hannigan | M | - |
Simbec-Orion Group Ltd.
![]() Simbec-Orion Group Ltd. Pharmaceuticals: MajorHealth Technology Simbec-Orion Group Ltd. provides contract research services for rare and orphan conditions. The firm offers services for oncology, orphan diseases, respiratory, dermatology, infectious vaccines and diseases. The company was founded in 2014 and is headquartered in Pentrebach, the United Kingdom. | 9 anni |
Anand Jagdishchandra Jain | M | 48 |
Simbec-Orion Group Ltd.
![]() Simbec-Orion Group Ltd. Pharmaceuticals: MajorHealth Technology Simbec-Orion Group Ltd. provides contract research services for rare and orphan conditions. The firm offers services for oncology, orphan diseases, respiratory, dermatology, infectious vaccines and diseases. The company was founded in 2014 and is headquartered in Pentrebach, the United Kingdom. | - |
Adam Richardson | M | - |
Simbec-Orion Group Ltd.
![]() Simbec-Orion Group Ltd. Pharmaceuticals: MajorHealth Technology Simbec-Orion Group Ltd. provides contract research services for rare and orphan conditions. The firm offers services for oncology, orphan diseases, respiratory, dermatology, infectious vaccines and diseases. The company was founded in 2014 and is headquartered in Pentrebach, the United Kingdom. | 5 anni |
Amanda Gibbon | F | - |
Rarecan Ltd.
![]() Rarecan Ltd. Miscellaneous Commercial ServicesCommercial Services Rarecan Ltd. is a patient-centric research platform that provides clinical trial recruitment and retention services. The company is based in Hexham, UK. The British company supports and augments recruitment through sites and existing site-to-site referral networks, and provides a patient concierge service through which patients can be actively supported during screening, enrollment, and throughout their participation. Rarecan helps patients with rare histological cancers to identify potentially suitable clinical trials. The CEO of the company is Piers Kotting. | - |
Claire Heron | F | - |
Rarecan Ltd.
![]() Rarecan Ltd. Miscellaneous Commercial ServicesCommercial Services Rarecan Ltd. is a patient-centric research platform that provides clinical trial recruitment and retention services. The company is based in Hexham, UK. The British company supports and augments recruitment through sites and existing site-to-site referral networks, and provides a patient concierge service through which patients can be actively supported during screening, enrollment, and throughout their participation. Rarecan helps patients with rare histological cancers to identify potentially suitable clinical trials. The CEO of the company is Piers Kotting. | - |
Piers Kotting | M | - |
Rarecan Ltd.
![]() Rarecan Ltd. Miscellaneous Commercial ServicesCommercial Services Rarecan Ltd. is a patient-centric research platform that provides clinical trial recruitment and retention services. The company is based in Hexham, UK. The British company supports and augments recruitment through sites and existing site-to-site referral networks, and provides a patient concierge service through which patients can be actively supported during screening, enrollment, and throughout their participation. Rarecan helps patients with rare histological cancers to identify potentially suitable clinical trials. The CEO of the company is Piers Kotting. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
James Openshaw | M | 58 |
Simbec-Orion Group Ltd.
![]() Simbec-Orion Group Ltd. Pharmaceuticals: MajorHealth Technology Simbec-Orion Group Ltd. provides contract research services for rare and orphan conditions. The firm offers services for oncology, orphan diseases, respiratory, dermatology, infectious vaccines and diseases. The company was founded in 2014 and is headquartered in Pentrebach, the United Kingdom. | - |
Martin Walton | M | 61 |
Simbec-Orion Group Ltd.
![]() Simbec-Orion Group Ltd. Pharmaceuticals: MajorHealth Technology Simbec-Orion Group Ltd. provides contract research services for rare and orphan conditions. The firm offers services for oncology, orphan diseases, respiratory, dermatology, infectious vaccines and diseases. The company was founded in 2014 and is headquartered in Pentrebach, the United Kingdom. | 3 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Regno Unito | 12 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Anita Cooper
- Contatti personali